Trials / Completed
CompletedNCT03196778
Low Dose Hemi-body Radiation For Recurrent Prostate Cancer
Non-Targeted Low Dose Radiotherapy For Recurrent Prostate Cancer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- Juravinski Cancer Center · Academic / Other
- Sex
- Male
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Older studies in animals and humans have shown cancer responses to very low doses of whole-body or hemi-body radiation. To study the effects of low doses of radiation in patients with recurrent prostate cancer, investigators will enroll up to 21 patients for 10 fractions of low dose radiation, delivered over 5 weeks. Participants will be followed on study for 12 months, capturing PSA, CBC, QoL and blood samples for immunological analysis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Low Dose Radiotherapy | Patients will receive 10 fractions of very low dose hemi-body radiation, delivered, twice per week, over five weeks |
Timeline
- Start date
- 2017-09-25
- Primary completion
- 2022-07-18
- Completion
- 2022-07-18
- First posted
- 2017-06-23
- Last updated
- 2022-08-10
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT03196778. Inclusion in this directory is not an endorsement.